Evidence map›Paper›PMID 36012015›Full record

ArticleInternational journal of environmental research and public health2022

The Role of Context in Integrating Buprenorphine into a Drop-In Center in Kampala, Uganda, Using the Consolidated Framework for Implementation Research.

Julia Dickson-Gomez, Sarah Krechel, Dan Katende, Bryan Johnston, Wamala Twaibu, Laura Glasman, Moses Ogwal, Geofrey Musinguzi

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Julia Dickson-GomezInstitute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Sarah KrechelInstitute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Dan KatendeUganda Harm Reduction Network, Kampala 31762, Uganda.
Bryan JohnstonInstitute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI 53226, USA.ORCID 0000-0002-2521-6989
Wamala TwaibuUganda Harm Reduction Network, Kampala 31762, Uganda.
Laura GlasmanInstitute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Moses OgwalSchool of Public Health, Makerere University, Kampala 7072, Uganda.
Geofrey MusinguziSchool of Public Health, Makerere University, Kampala 7072, Uganda.

Funding

Integration of buprenorphine into a multi-component harm reduction program fro people who inject drugs in Kampala, UgandaR34DA052178 · NIDA · MEDICAL COLLEGE OF WISCONSIN · PI DICKSON-GOMEZ, JULIA B · 2020 to 2022
$565k
NIDA NIH HHS R34 DA052178
6 · The paper itself

Abstract

backgroundAlthough Africa has long borne the brunt of the human immunodeficiency virus (HIV) epidemic, until recently, the continent has been considered largely free of illicit drug use and injection drug use in particular. In Uganda, the number of people who use or inject drugs (PWUD and PWID, respectively) has increased, and PWID are a key population at high risk for human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infection. However, harm reduction practices, including providing clean injection equipment and medication-assisted treatment (MAT), have only recently been piloted in the country. This project aims to integrate buprenorphine into a harm reduction drop-in center (DIC).

methodsThe Consolidated Framework for Implementation Research was used to guide our preparations to integrate buprenorphine into existing practices at a harm reduction DIC. We conducted key informant interviews with members of a community advisory board and DIC staff to document this process, its successes, and its failures.

resultsResults indicate that criminalization of drug use and stigmatization of PWUD challenged efforts to provide buprenorphine treatment in less regulated community settings.

conclusionsDIC staff and their commitment to harm reduction and advocacy facilitated the process of obtaining necessary approvals.

Indexed as

BuprenorphineHepatitis CHIV InfectionsSubstance Abuse, IntravenousSubstance-Related DisordersHarm ReductionHumansUgandaBuprenorphineAfricabuprenorphineopioid use disorderpeople who use opioidssyringe service programsUganda

Identifiers

PMID36012015
PMCPMC9407835

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.